Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US experts call for novel approaches to monitoring clinical trials

This article was originally published in SRA

Executive Summary

The Clinical Trials Transformation Initiative (CTTI), a major US venture to modernise the way that clinical trials are conducted, has published a summary of its deliberations on how sponsors can best monitor the conduct of clinical trials1,2. The discussions on how to monitor the conduct of clinical trials effectively and efficiently as a component of quality were published in May by the CTTI, which comprises experts from the Food and Drug Administration and Duke University.

Advertisement
Advertisement
UsernamePublicRestriction

Register

MT038852

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel